Table 5.
Glucose abnormalities and hepatocellular carcinoma in hepatitis C virus-infected patients
Ref. | Year | Country | Patient number | Patient profile | Association | Statistical method | Association DM and HCC | Statistics |
Diabetes mellitus/insulin resistance in HCV-related HCC | ||||||||
K-Kutala et al[15] | 2014 | France | 162 | HCC, not treated for HCV | DM and HCC | Multivariate | Yes3 | HR = 3.13 [1.17, 8.38]; P = 0.0223 |
Hung et al[115] | 2010 | Taiwan | 188 | 59 HCC; 129 non-HCC | DM and HCC | Multivariate | Yes | OR = 11.6 [2.500, 53.800]; P = 0.002 |
Hung et al[115] | 2010 | Taiwan | 188 | 59 HCC; 129 non-HCC | HOMA-IR and HCC | Multivariate | Yes | OR = 2.0 [1.35, 3]; P = 0.001 |
Khattab et al[116] | 2012 | Egypt | 294 | 147 HCC; 147 non-HCC | HOMA-IR and HCC | Multivariate | Yes | OR = 2.5 [1.7, 3.69]; P = 0.001 |
Mohamed et al[73] | 2011 | Egypt | 100 | 50 HCC; 50 non-HCC; 20 non HCV | HOMA-IR and HCC | Univariate | No | NS |
Diabetes mellitus/insulin resistance and development of HCC in HCV-infected patients | ||||||||
Chen et al[117] | 2008 | Taiwan | 1095 | - | DM and HCC | Multivariate | Yes | OR = 3.52 [1.29, 9.24] |
Veldt et al[16] | 2008 | Europe | 541 | DM and HCC | Multivariate | Yes3 | OR = 3.28 [1.35, 7.97]; P = 0.0093 | |
Konishi et al[118] | 2009 | Japan | 197 | Non DM, treated for HCV | DM1 and HCC | Multivariate | Yes | HR = 4.63 [1.677, 12.766]; P = 0.003 |
Hung et al[14] | 2010 | Taiwan | 1470 | Treated for HCV | DM and HCC | Multivariate | Yes2 | HR = 4.32 [1.23, 15.25]; P = 0.0232 |
Nkontchou et al[119] | 2010 | France | 248 | Cirrhotics | HOMA-IR and HCC | Multivariate | Yes | HR = 1.10 [1.01, 1.21]; P = 0.026 |
Takahashi et al[120] | 2011 | Japan | 203 | Non DM, treated for HCV | DM1 and HCC | Multivariate | Yes | HR = 6.9 [1.7, 28.4]; P < 0.05 |
Arase et al[121] | 2013 | Japan | 4302 | Non treated for HCV | DM and HCC | Multivariate | Yes | HR = 1.73 [1.3, 2.3]; P < 0.001 |
Elkrief et al[45] | 2014 | France | 348 | Cirrhotics | DM | Multivariate | Yes | HR = 1.938 [1.129 , 3.328]; P = 0.016 |
Toyoda et al[122] | 2015 | Japan | 522 | Patients with SVR | DM and HCC | Multivariate | Yes | HR = 2.08 [1.0170, 4.0133]; P = 0.045 |
Lai et al[123] | 2006 | Taiwan | 2141 | - | DM and HCC | Multivariate | No | NS |
Chen et al[124] | 2013 | Taiwan | 5186 | - | DM and HCC | Multivariate | No | NS |
Association of abnormal post-challenge hyperglycaemia and HCC;
Only in SVR patients without cirrhosis;
Only in advanced liver fibrosis. HCV: Hepatitis virus infection; HCC: Hepatocellular carcinoma; SVR: Sustained virological response; HOMA-IR: Homeostasis Model Assessment of Insulin Resistance; IR: Insulin resistance; DM: Diabetes mellitus; NS: Not significant.